Decheng Capital Global Life Sciences Fund IV, L.P.

13F Holdings History for Aardvark Therapeutics, Inc. - Common Stock, par value $0.00001 per share

Investment type: Equity / Common Stock, par value $0.00001 per share
Latest Disclosed Ownership: 3.92M shares
Security Ownership: 18.3%

Xiangmin Cui ownership in Aardvark Therapeutics, Inc. Common Stock, par value $0.00001 per share

2025-02-24 - Xiangmin Cui has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 3.92M shares of Aardvark Therapeutics, Inc. Common Stock, par value $0.00001 per share. This represents 18.3% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Xiangmin Cui	18.3%			3.92M				13G	2/14/2025	24 Feb 2025 16:16:17